Study S002817

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy and Safety of Petrelintide Co-Administered With RO7795068 in Adults With Obesity or Overweight

ClinicalTrials.gov record

Registration

Registration: NCT07589686
Acronym: ZYNERGY
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 486
Start: 2026-09-30
Primary completion: 2027-11-12
Lead sponsor: Hoffmann-La Roche
Conditions: Obesity or Overweight
Interventions: DRUG:Petrelintide; COMBINATION_PRODUCT:Enicepatide; DRUG:Petrelintide-matching Placebo; COMBINATION_PRODUCT:Enicepatide-matching Placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Percentage Change in Body Weight between Arms 1 and 6 [From Baseline to Week 40]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.